- Home
- ARQT vs NSP Comparison
ARQT vs NSP Comparison
Compare ARQT & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- NSP
- Stock Information
- Founded
- ARQT 2016
- NSP 1986
- Country
- ARQT United States
- NSP United States
- Employees
- ARQT N/A
- NSP N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- NSP Professional Services
- Sector
- ARQT Health Care
- NSP Consumer Discretionary
- Exchange
- ARQT Nasdaq
- NSP Nasdaq
- Market Cap
- ARQT 1.7B
- NSP 2.0B
- IPO Year
- ARQT 2020
- NSP 1997
- Fundamental
- Price
- ARQT $15.99
- NSP $55.58
- Analyst Decision
- ARQT Strong Buy
- NSP Hold
- Analyst Count
- ARQT 7
- NSP 4
- Target Price
- ARQT $19.00
- NSP $58.33
- AVG Volume (30 Days)
- ARQT 1.8M
- NSP 856.4K
- Earning Date
- ARQT 08-06-2025
- NSP 08-01-2025
- Dividend Yield
- ARQT N/A
- NSP 4.46%
- EPS Growth
- ARQT N/A
- NSP N/A
- EPS
- ARQT N/A
- NSP 1.05
- Revenue
- ARQT $263,464,999.00
- NSP $6,695,000,000.00
- Revenue This Year
- ARQT $61.83
- NSP $4.83
- Revenue Next Year
- ARQT $36.55
- NSP $5.99
- P/E Ratio
- ARQT N/A
- NSP $52.82
- Revenue Growth
- ARQT 99.50
- NSP 2.40
- 52 Week Low
- ARQT $8.03
- NSP $44.14
- 52 Week High
- ARQT $17.75
- NSP $95.98
- Technical
- Relative Strength Index (RSI)
- ARQT 56.88
- NSP 51.92
- Support Level
- ARQT $15.43
- NSP $52.56
- Resistance Level
- ARQT $17.29
- NSP $55.74
- Average True Range (ATR)
- ARQT 0.97
- NSP 2.37
- MACD
- ARQT 0.06
- NSP 0.66
- Stochastic Oscillator
- ARQT 63.70
- NSP 95.27
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.